EHS unveils Future of Healthcare with two revolutionary projects

Emirates Health Services (EHS) is making waves at Arab Health 2025, with groundbreaking innovations set to redefine patient care. Under the theme The Future of Healthcare, EHS is spotlighting two revolutionary projects that promise to reshape the treatment of chronic diseases: the Total Artificial Heart and Islet Cell Allo-Transplantation. These cutting-edge advancements aren't just new for the region-they're a global game changer.
"We're committed to pushing boundaries in healthcare," said Dr. Essam Al Zarooni, Acting Executive Director of the Medical Services Sector at EHS. "The projects we're unveiling mark a major leap forward in treating conditions like heart disease and type 1 diabetes. They align with the National Strategy for Wellbeing 2031, ensuring better healthcare outcomes for our communities."
How does it work?
Let's look at each of the two projects:
Total Artificial Heart
Imagine a failing heart replaced by a machine-except this machine mimics the real thing, pumping blood with precision and efficiency. The Total Artificial Heart, developed in collaboration with the Texas Heart Institute, is just that. It's built around a state-of-the-art titanium pump that leverages magnetic technology to circulate blood seamlessly, fully replacing the function of a failing heart.
Following successful transplants in the United States, the device has earned the FDA's seal of approval. Now, EHS is gearing up to introduce it to Al Qassimi Hospital in Sharjah, bringing a life-saving option to patients battling advanced heart failure.
Islet Cell Allo-Transplantation
Diabetes treatment is about to get a radical makeover. Islet Cell Allo-Transplantation, developed in partnership with the University of Chicago, offers a breakthrough approach for type 1 diabetes patients. Instead of undergoing complex pancreatic transplants, patients receive a simple cell infusion into the liver using a fine catheter.
The impact? Patients regain blood sugar control, cutting the risk of severe hypoglycemia and, in some cases, eliminating the need for insulin altogether. Clinical trials have delivered promising results, earning this procedure FDA approval as a safer, more effective alternative.
Why does it matter?
Heart failure and type 1 diabetes affect millions worldwide, with treatment often being complex, invasive, and life-altering. The introduction of these technologies represents a seismic shift in how these conditions are managed.
The Total Artificial Heart isn't just a stopgap — it's a lifeline for those awaiting transplants or dealing with severe heart disease. Meanwhile, Islet Cell Allo-Transplantation could liberate diabetes patients from a lifetime of insulin dependence, offering them a renewed lease on life.
"This is about more than technology — it's about giving people a future," Dr. Al Zarooni emphasized. "By bringing these innovations to the UAE, we're not just keeping up with medical advancements; we're setting new benchmarks."
The context
EHS' ambitious initiatives are part of a broader national vision. They align with the UAE's 'We the UAE 2031' strategy and the UAE Centennial 2071 Plan, both of which prioritize next-generation healthcare solutions.
The region has been on a fast track to becoming a global hub for medical excellence, investing heavily in pioneering technologies that enhance both accessibility and quality of care. By embracing transformative solutions like artificial hearts and cellular transplants, the UAE is positioning itself at the forefront of medical innovation.
💡Did you know?
You can take your DHArab experience to the next level with our Premium Membership.👉 Click here to learn more
🛠️Featured tool
monday
Built for a new way of working, monday is a stunning project management tool that enables the whole team to collaborate, share updates, see the performance, comments, and more.
👉 Click here to learn more
